About Synthetic Genomics
Synthetic Genomics is a company based in San Diego (United States) founded in 2005.. Synthetic Genomics has raised $75 million across 4 funding rounds from investors including HHS, Biotechonomy and Draper Frontier. The company has 190 employees as of December 31, 2022. Synthetic Genomics has completed 1 acquisition, including Febit. Synthetic Genomics offers products and services including Algae Biofuel. Synthetic Genomics operates in a competitive market with competitors including Amyris, Syngenta, Avidity Biosciences, AskBio and Univercells, among others.
- Headquarter San Diego, United States
- Employees 190 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Synthetic Genomics, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Synthetic Genomics
Synthetic Genomics offers a comprehensive portfolio of products and services, including Algae Biofuel. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Optimizes microalgae to create renewable oil for decarbonizing transportation.
Unlock access to complete
Unlock access to complete
Funding Insights of Synthetic Genomics
Synthetic Genomics has successfully raised a total of $75M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $387.63 thousand completed in December 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Grant — $387,632
-
First Round
First Round
(23 Dec 2005)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2015 | Amount | Grant - Synthetic Genomics | Valuation |
investors |
|
| Feb, 2013 | Amount | Series C - Synthetic Genomics | Valuation |
investors |
|
| Dec, 2010 | Amount | Series C - Synthetic Genomics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Synthetic Genomics
Synthetic Genomics has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Biotechonomy and Draper Frontier. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Seed & early-stage micro VC firm investing in the US
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Synthetic Genomics
Synthetic Genomics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Febit. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Geniom platform and services are provided for genomic researchers.
|
2005 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Synthetic Genomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Synthetic Genomics Comparisons
Competitors of Synthetic Genomics
Synthetic Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amyris, Syngenta, Avidity Biosciences, AskBio and Univercells, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of renewable products for industrial solutions
|
|
| domain | founded_year | HQ Location |
Crop protection solutions and hybrid seeds are provided for farming.
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Gene and protein therapies are developed for treating various diseases.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Synthetic Genomics
Frequently Asked Questions about Synthetic Genomics
When was Synthetic Genomics founded?
Synthetic Genomics was founded in 2005.
Where is Synthetic Genomics located?
Synthetic Genomics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Is Synthetic Genomics a funded company?
Synthetic Genomics is a funded company, having raised a total of $75M across 4 funding rounds to date. The company's 1st funding round was a Series C of $35M, raised on Dec 23, 2005.
How many employees does Synthetic Genomics have?
As of Dec 31, 2022, the latest employee count at Synthetic Genomics is 190.
What does Synthetic Genomics do?
Synthetic Genomics (SGI) engages in synthesizing and programming DNA by developing and utilizing the technologies in synthetic genomics. SGI provides solutions to three end markets: research, bioproduction and applied products. Its research segment is focused on genomics solutions for academic and commercial RD organizations. Its commercial products and services include instrumentation, reagents, DNA synthesis services, and bioinformatics services and software. In 2015, the company launched the BioXP 3200 system, a benchtop DNA printer that takes sequencing data and produces high-quality DNA fragments. It is also focussed on improving existing production hosts and developing new synthetic production hosts for new and more efficient routes to bioproducts including materials, chemicals, energy and other goods derived from renewable biological resources.
Who are the top competitors of Synthetic Genomics?
Synthetic Genomics's top competitors include Syngenta, Sutro Biopharma and Avidity Biosciences.
What products or services does Synthetic Genomics offer?
Synthetic Genomics offers Algae Biofuel.
How many acquisitions has Synthetic Genomics made?
Synthetic Genomics has made 1 acquisition, including Febit.
Who are Synthetic Genomics's investors?
Synthetic Genomics has 3 investors. Key investors include HHS, Biotechonomy, and Draper Frontier.